| Breakdown | TTM | Dec 2025 | Mar 2025 | Mar 2024 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 53.49M | 54.20M | 55.64M | 57.05M | 56.02M | 56.14M |
| Gross Profit | 21.94M | 18.46M | 23.20M | 23.76M | 18.05M | 24.27M |
| EBITDA | 4.36M | 3.64M | 2.74M | 2.45M | 2.38M | 5.45M |
| Net Income | 1.27M | 808.00K | 435.00K | -4.29M | -3.49M | 703.00K |
Balance Sheet | ||||||
| Total Assets | 23.18M | 27.58M | 20.04M | 20.85M | 30.73M | 28.97M |
| Cash, Cash Equivalents and Short-Term Investments | 1.99M | 1.83M | 2.30M | 1.41M | 1.52M | 1.90M |
| Total Debt | 7.14M | 7.17M | 3.44M | 5.69M | 6.94M | 5.91M |
| Total Liabilities | 18.83M | 22.88M | 16.14M | 17.40M | 24.12M | 18.11M |
| Stockholders Equity | 4.35M | 4.70M | 3.90M | 3.45M | 6.61M | 9.77M |
Cash Flow | ||||||
| Free Cash Flow | 917.00K | 89.00K | 2.68M | 1.63M | -729.00K | 94.00K |
| Operating Cash Flow | 1.42M | 734.00K | 3.13M | 1.70M | -317.00K | 4.24M |
| Investing Cash Flow | -661.00K | -772.00K | -538.00K | 82.00K | 154.00K | -4.14M |
| Financing Cash Flow | -988.00K | -492.00K | -1.71M | -1.57M | 246.00K | -1.75M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
74 Outperform | €3.06B | 16.37 | 17.50% | 6.73% | 6.31% | 10.31% | |
62 Neutral | €140.18B | 18.88 | 14.36% | 3.28% | 1.37% | -26.06% | |
61 Neutral | $37.18B | 12.37 | -10.20% | 1.83% | 8.50% | -7.62% | |
61 Neutral | €4.91B | 19.51 | 6.31% | 7.04% | -5.62% | ― | |
57 Neutral | €4.09B | 58.54 | 2.24% | 0.21% | 5.05% | -23.13% | |
47 Neutral | €15.21M | -11.37 | 34.76% | ― | -3.38% | 1326.47% |